Summary from the original article
The changes must include information about a potentially increased risk of a rare but serious eye condition that can cause permanent vision loss.
By Bernama ·
AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.
Upgrade this serverThe changes must include information about a potentially increased risk of a rare but serious eye condition that can cause permanent vision loss.
2 days ago · freemalaysiatoday.com · You are reading this one
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
2 days ago · cbsnews.com
The US Food and Drug Administration (FDA) is requiring manufacturers of GLP-1 medicines to update their safety labels to warn of a potential increased risk of a rare but serious eye condition that can cause permanent vision loss.
2 days ago · euronews.com
